Sanara Medtech Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the Annual Meeting of Shareholders held by Sanara Medtech Inc. on June 4, 2026. The filing details the voting outcomes for four specific proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting results.
Material Changes and Voting Results
A total of 6,701,593 shares were present in person or by proxy. All four proposals were approved:
- Proposal 1 (Election of Directors): Nine nominees were elected to the Board of Directors for one-year terms. While all were approved, significant votes were withheld for several directors, ranging from approximately 109,000 to 328,000 votes. Broker non-votes totaled 1,296,806.
- Proposal 2 (Auditor Ratification): Shareholders ratified the appointment of Weaver and Tidwell, L.L.P. as the independent registered public accounting firm for the fiscal year ending December 31, 2026. The vote was overwhelmingly in favor (6,696,035 for vs. 2,198 against).
- Proposal 3 (Say-on-Pay): Shareholders approved the compensation of named executive officers on an advisory basis. Votes cast for were 5,280,546, with 57,530 against.
- Proposal 4 (Say-on-Pay Frequency): Shareholders voted to conduct future advisory votes on executive compensation every three years. This option received 4,296,133 votes, compared to 991,414 for a one-year frequency and 51,146 for a two-year frequency.
Guidance, Outlook, and Management Commentary
Based on the voting results for Proposal 4, the Board determined that future advisory votes on executive compensation will occur every three years. This policy is effective until the next shareholder vote on this frequency, expected at the 2029 annual meeting. The filing references a Definitive Proxy Statement filed on April 17, 2026, for detailed descriptions of the proposals.
Investor Verification Checklist
- Verify the specific reasons for the significant number of votes withheld for certain director nominees (Proposal 1).
- Review the Definitive Proxy Statement (Schedule 14A) filed on April 17, 2026, for detailed executive compensation data and director biographies.
- Confirm the impact of the 1,296,806 broker non-votes on the overall voting power dynamics.
- Monitor the implementation of the new three-year executive compensation advisory vote cycle.